~~<i id='76429869ED'><strike id='76429869ED'><tt id='76429869ED'><pre id='76429869ED'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

focus

author：entertainment 2025-09-30 00:34:21 - browse：441

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Advances in CAR

leisure time

hotspot

entertainment

hotspot

focus

HumanembryonicstemcellsAnnieCavanagh/WellcomeImagesTheFoodandDrugAdministrationonThursdayunveiledase

WSS

Flagship Pioneering startup Sonata Therapeutics lays off 21

Weight loss drugs aren’t covered by Obamacare. That may change

Congress may force more Covid

Medicaid rebukes states for mistakenly disenrolling children

What drug price negotiations mean for Medicare Part D

How generative AI is inspiring dreams of a health data revolution

hotspot

focus

Featured Speakers

leisure time

Peter Hotez and the public health issue of online harassment

Researchers tackle phage therapy hurdles for wider adoption

Walensky prepares to leave CDC — and Congress — behind

Illumina names Agilent executive as new CEO

Virginia high school admissions case could be legal follow

Obamacare plans could cover weight loss drugs

Novavax promises a turnaround & Lilly roils the obesity market

The (many) problems with a new study criticizing cancer screening

Heart attack and stroke risk calculators need revising

Weighted lottery helped low

hotspot

Stem cell treatment guidelines are released by FDA

New CMS data security rules will hurt Medicare, Medicaid research

Medicare Advantage enrollment hits roughly 33.4 million

ALS advocates say criticism of new drugs misses bigger picture

Ethical issues complicate the benefits of medical crowdfunding

Abridge raises $150m as clinical notes automation market heats up

entertainment

hotspot

hotspot

focus